2018-11-06T08:28:31-06:00 2017-12-31 390859910 BAKER TILLY VIRCHOW KRAUSE LLP 1650 MARKET STREET SUITE 4500 PHILADELPHIA PA 191037341 990 2017-01-01 453083156 THE CHILDREN'S ONCOLOGY GROUP FOUNDATION INC CHIL 2674253139 3501 CIVIC CENTER BLVD CTRB 10060 PHILADELPHIA PA 19104 PETER C ADAMSON MD PRESIDENT AND DIRECTOR 2674253139 2018-11-05 1 JULIUS C GREEN CPA P00350393 2159720701 X 96.89.178.186 2018-11-05 16:26:42 ES P F2402B78FC355C8D5AEB106FC1FA7B3FDC501D48 BF90B4BE16E9AE312C0D8383967EBAED4A365E8B 2017 2018-06-14 16:35:46Z PETER C ADAMSON MD 3501 CIVIC CENTER BLVD CTRB 10060 PHILADELPHIA PA 19104 9271563 0 X WWW.COG-FOUNDATION.ORG X 2011 PA A FOUNDATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH. 6 6 0 3 0 0 8847315 9229839 557777 18246 5010 17642 0 5836 9410102 9271563 7206460 7412802 0 0 0 0 0 0 24946 1101182 1529654 8307642 8942456 1102460 329107 17277501 17660250 217831 236149 17059670 17424101 X THE CHILDREN'S ONCOLOGY GROUP FOUNDATION, INC. (THE FOUNDATION), HELPS SUPPORT THE RESEARCH OF THE CHILDREN'S ONCOLOGY GROUP (COG), WHICH IS THE WORLD'S LARGEST ORGANIZATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH. 0 0 8889467 7412802 18246 THE CHILDREN'S ONCOLOGY GROUP FOUNDATION, INC. ENABLES COG'S LEADERSHIP, COMPRISED OF A TEAM OF DOCTORS, NURSES, LABORATORY SCIENTISTS AND OTHER ALLIED PROFESSIONALS, THE ABILITY TO DIRECT THE RESOURCES RAISED FOR CHILDHOOD CANCER RESEARCH TO THE AREAS OF HIGHEST NEED AND OPPORTUNITY. THE FOUNDATION ALLOWS PHILANTHROPIC FUNDS FROM INDIVIDUAL SUPPORTERS AND ORGANIZATIONS TO GO DIRECTLY TO COG TO FUND ITS MUCH NEEDED RESEARCH. IN AN ERA OF RAPID SCIENTIFIC DISCOVERY, THIS DIRECT LINK ALLOWS COG RESEARCHERS TO RESPOND QUICKLY TO NEW DISCOVERIES WITH THE GREATEST POTENTIAL TO BENEFIT CHILDREN WITH CANCER. THE CHILDREN'S ONCOLOGY GROUP HAS OVER 50 ACTIVE CLINICAL TRIALS OPEN AT ANY GIVEN TIME. THESE TRIALS INCLUDE FRONT-LINE TREATMENT FOR MANY TYPES OF CHILDHOOD CANCERS, STUDIES AIMED AT DETERMINING THE UNDERLYING BIOLOGY OF THESE DISEASES, AND TRIALS INVOLVING NEW AND EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP. THE CHILDREN'S ONCOLOGY GROUP RESEARCH HAS TURNED CHILDREN'S CANCER FROM A VIRTUALLY INCURABLE DISEASE 50 YEARS AGO TO ONE WITH A COMBINED 5-YEAR SURVIVAL RATE OF 80% TODAY. OUR GOAL IS TO CURE ALL CHILDREN AND ADOLESCENTS WITH CANCER, REDUCE THE SHORT AND LONG-TERM COMPLICATIONS OF CANCER TREATMENTS, AND DETERMINE THE CAUSES AND FIND WAYS TO PREVENT CHILDHOOD CANCER. PROJECT: EVERYCHILD: CHILDREN'S ONCOLOGY GROUP'S PROJECT: EVERYCHILD IS OUR AMBITIOUS INITIATIVE TO FIND BETTER CURES FOR EVERY TYPE OF CHILDHOOD CANCER, NO MATTER HOW RARE. ALL CHILDREN WITH CANCER CARED FOR AT COG'S MORE THAN 200 PEDIATRIC CANCER PROGRAMS WILL BE ABLE TO PARTICIPATE IN PROJECT: EVERYCHILD. 8889467 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 0 0 0 0 PA X X PETER C ADAMSON MD PRESIDENT 2674253139 3501 CIVIC CENTER BLVD CTRB 10060 PHILADELPHIA PA 19104 X PETER C ADAMSON MD PRESIDENT & DIRECTOR 2.00 X X 0 0 0 JOSEPH NEGLIA MD MPH SECRETARY 0.50 X X 0 0 0 NAOMI WINICK MD TREASURER 0.50 X X 0 0 0 M BROOKE BERNHARDT PHARMD MS B DIRECTOR 0.50 X 0 0 0 SUSAN M BLANEY MD DIRECTOR 0.50 X 0 0 0 VIKRAMJIT SINGH KANWAR MBBS DIRECTOR (RESIGNED NOV. '17) 0.50 X 0 0 0 JUDY L FELGENHAUER MD DIRECTOR 0.50 X 0 0 0 0 0 0 0 0 0 0 PUBLIC HEALTH INSTITUTE 555 12TH STREET 10TH FLOOR OAKLAND CA 94607 RESEARCH SERVICES 284086 DILTS & PARTNERS LLC 5317 CORINTHIAN BAY DR PLANO TX 75093 CONSULTING SERVICES 201258 2 9229839 9229839 CONFERENCE FEES 900099 15350 15350 PROGRAM SERVICE REV. 900099 2896 2896 18246 15627 15627 2015 0 2015 2015 2015 EXHIBITION INCOME 900099 5500 5500 MISC INCOME 900099 336 336 5836 9271563 18246 0 23478 X 6813552 6813552 599250 599250 17848 11938 3601 2309 1419422 1379356 23196 16870 7028 4732 838 1458 34874 30760 48 4066 29154 29154 10732 10732 8113 8106 4 3 691 490 115 86 1184 839 197 148 MISCELLANEOUS EXPENSE 358 358 STATE REGISTRATION FEE 250 200 44 6 8942456 8889467 28043 24946 131123 108008 9414633 10195949 7026027 6070000 449340 482546 2072 1727 1036 345 253092 803402 2250 0 17277501 17660250 62237 73651 155594 162498 217831 236149 X 1937430 1992129 15122240 15431972 17059670 17424101 17277501 17660250 329107 35324 0 X 0 1 X 0 0 X 9595377 10204963 9927823 8847315 9229839 47805317 9595377 10204963 9927823 8847315 9229839 47805317 43218 47762099 3616 579 1095 4476 15627 25393 2577 5836 8413 47839123 576023 0.99840 0.99870 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING SALES - 2013 AMOUNT: $ 2,577. MISCELLANEOUS INCOME - 2017 AMOUNT: $ 336. EXHIBITION INCOME - 2017 AMOUNT: $ 5,500. 2072 1727 345 345 X 9335923 35324 29036 64360 9271563 0 9271563 8971492 29036 29036 8942456 0 8942456 PART X, LINE 2: THE FOUNDATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN THE FINANCIAL STATEMENTS USING A RECOGNITION THRESHOLD OF MORE LIKELY THAN NOT AS TO WHETHER THE UNCERTAINTY WILL BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT DETERMINED THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD. THE FEDERAL FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER FILED. 1 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 189750 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 23000 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 1800 NORTH AMERICA 0 0 GRANTMAKING 384700 0 0 0 0 0 0 599250 0 599250 NORTH AMERICA TO CURE CHILDREN AND IMPROVE CAPACITY OF QUALITY AND TREATMENT 384700 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) TO CURE CHILDREN AND IMPROVE CAPACITY OF QUALITY AND TREATMENT 23000 CHECK EAST ASIA AND THE PACIFIC TO CURE CHILDREN AND IMPROVE CAPACITY OF QUALITY AND TREATMENT 189550 CHECK 1 0 0 0 0 0 0 PART I, LINE 2: THE FOUNDATION RECEIVES A FULL ACCOUNTING OF GRANTEE EXPENDITURES ON AT LEAST AN ANNUAL BASIS, AND REQUIRES GRANTEE ORGANIZATIONS TO RETAIN ALL FINANCIAL RECORDS, SUPPORTING DOCUMENTS, RESEARCH DATA AND OTHER PERTINENT RECORDS FOR AT LEAST THREE YEARS FOLLOWING THE DATE OF SUBMISSION OF A FINAL EXPENDITURE REPORT. IN ADDITION, THE FOUNDATION CROSS-REFERENCES GRANTEE ORGANIZATIONS WITH THE OFFICE OF FOREIGN ASSETS CONTROL'S SPECIFICALLY DESIGNATED NATIONAL AND BLOCKED PERSONS LIST. PART I, LINE 3: IN ACCORDANCE WITH IRS INSTRUCTIONS, ALL AMOUNTS REPORTED IN PARTS I AND II OF SCHEDULE F ARE REPORTED USING THE ACCRUAL BASIS OF ACCOUNTING, THE SAME METHOD OF ACCOUNTING USED IN THE FINANCIAL STATEMENTS. 1 CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE 3615 CIVIC CENTER BOULEVARD PHILADELPHIA PA 19104 231352166 501(C)(3) 4949800 PER-CASE REIMBURSEMENT, PROJECT:EVERYCHILD THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL 700 CHILDRENS DRIVE COLUMBUS OH 43205 316056230 501(C)(3) 1021565 PROJECT:EVERYCHILD, REFERENCE LABORATORIES UNIVERSITY OF ALABAMA AT BIRMINGHAM 701 20TH ST S - AB 921 BIRMINGHAM AL 35294 636005396 501(C)(3) 241425 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 170000 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT CHILDREN'S RESEARCH INSTITUTE 111 MICHIGAN AVENUE NW SUITE 5400 WASHINGTON DC 20010 521654453 100000 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT WAYNE STATE UNIVERSITY 5057 WOODWARD AVENUE DETROIT MI 48202 386028429 501(C)(3) 80360 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT NYU MEDICAL CENTER 550 FIRST AVENUE NEW YORK NY 10016 135562309 501(C)(3) 50000 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT ST JUDE CHILDREN'S RESEARCH HOSPITAL INC PO BOX 1000 DEPT 949 MEMPHIS TN 38148 620646012 501(C)(3) 50000 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT ST P221 FRANKLIN BUILDING PHILADELPHIA PA 19104 231352685 501(C)(3) 45000 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT THE UNIVERSITY OF CHICAGO 5801 S ELLIS AVENUE CHICAGO IL 60637 362177139 501(C)(3) 30132 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT NATIONAL CANCER INSTITUTE BUILDING 31 ROOM 3A11 31 CENTER DRIVE BETHESDA MD 20892 75270 TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT 8 3 PART I, LINE 2: THE FOUNDATION RECEIVES A FULL ACCOUNTING OF GRANTEE EXPENDITURES ON AT LEAST ON ANNUAL BASIS, AND REQUIRES GRANTEE ORGANIZATIONS TO RETAIN ALL FINANCIAL RECORDS, SUPPORTING DOCUMENTS, RESEARCH DATA AND OTHER PERTINENT RECORDS FOR AT LEAST THREE YEARS FOLLOWING THE DATE OF SUBMISSION OF A FINAL EXPENDITURE REPORT. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS SHALL CONSIST OF THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER SHALL BE ENTITLED TO ONE VOTE ON EACH MATTER PRESENTED TO THE MEMBERS. FORM 990, PART VI, SECTION A, LINE 7B THE MEMBERS SHALL HAVE THE FOLLOWING EXCLUSIVE POWERS: (A) ADOPT AND AMEND STATEMENTS OF MISSION, PHILOSOPHY OR PURPOSE; (B) AMEND THE FOUNDATION'S ARTICLES OF INCORPORATION AND BYLAWS; (C) ELECT AND REMOVE, WITH OR WITHOUT CAUSE, THE DIRECTORS OF THE FOUNDATION. FORM 990, PART VI, SECTION A, LINE 8B THE FOUNDATION DOES NOT HAVE THE INSTITUTIONAL CAPACITY FOR SUCH A PROCESS TO OCCUR, SO THE BOARD OF DIRECTORS FUNCTIONS ON ITS OWN WITHOUT A SECONDARY COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B UNDER THE DIRECTION OF THE BOARD OF DIRECTORS' PRESIDENT, THE FOUNDATION CIRCULATES THE DRAFT VERSION OF THE FEDERAL FORM 990 FOR BOARD OF DIRECTORS' REVIEW BY EMAIL CORRESPONDENCE, AND THEN FORMALLY AT A SEMI-ANNUAL MEETING PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS REVIEWED REGULARLY AT THE FOUNDATION'S BOARD MEETINGS. BETWEEN MEETINGS, CONFERENCE CALLS AND EMAIL COMMUNICATIONS ARE UTILIZED FOR ANY INCIDENTIAL CONCERNS. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY PRESENTATION BY THE INTERESTED PERSON, THE INTERESTED PERSON SHALL LEAVE THE BOARD OF DIRECTORS' MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING DIRECTORS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION POSTS THE FEDERAL FORM 990, COI POLICY, AND OTHER GOVERNING DOCUMENTS ON ITS WEBSITE: HTTP://COG-FOUNDATION.ORG/DOCUMENTS.PHP. FORM 990, PART IX, LINE 11G OTHER FEES : PROGRAM SERVICE EXPENSES 1,379,356. MANAGEMENT AND GENERAL EXPENSES 23,196. FUNDRAISING EXPENSES 16,870. TOTAL EXPENSES 1,419,422.